DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Press-release

Decision Resources Study Identifies Drug Development Opportunities in Microvascular Complications of Diabetes

Decision Resources Study Identifies Drug Development Opportunities in Microvascular Complications of Diabetes

The well-publicized growth of the diabetic population worldwide has created a market opportunity for therapies that address three microvascular...

READ ARTICLE

Press-release

Increasing Diagnosed Prevalence of Type 2 Diabetes Is Driving Market Growth for Drugs to Treat the Microvascular Complications of Diabetes, According to a Decision Resources Study

Increasing Diagnosed Prevalence of Type 2 Diabetes Is Driving Market Growth for Drugs to Treat the Microvascular Complications of Diabetes, According to a Decision Resources Study

The well-publicized growth of the diabetic population worldwide has created market opportunity for therapies that address three microvascular...

READ ARTICLE

Press-release

Decision Resources Study Evaluates the Strategies of Eli Lilly and Other Depression Market Leaders to Combat Generic Competition

Decision Resources Study Evaluates the Strategies of Eli Lilly and Other Depression Market Leaders to Combat Generic Competition

Depression, a new study from Decision Resources, Inc., examines recent trends in the treatment of depression, growing generic competition within this...

READ ARTICLE

Press-release

Decision Resources Report Forecasts Substantial Market Opportunities for Therapies to Treat Hepatitis B and C Viruses

Decision Resources Report Forecasts Substantial Market Opportunities for Therapies to Treat Hepatitis B and C Viruses

The Prevention and Treatment of Select Viral Infections is a forthcoming DR Report from Decision Resources that evaluates the current and future...

READ ARTICLE

Press-release

Decision Resources Report Evaluates the Competitive Status of 14 Major Players in the Challenging CNS Pharmaceutical Marketplace

Decision Resources Report Evaluates the Competitive Status of 14 Major Players in the Challenging CNS Pharmaceutical Marketplace

Developing effective therapies for central nervous system (CNS) disorders is one of the most challenging tasks facing the pharmaceutical industry and...

READ ARTICLE

Press-release

Decision Resources Study Projects Robust Growth in the Ovarian Cancer Drug Market

Decision Resources Study Projects Robust Growth in the Ovarian Cancer Drug Market

Ovarian cancer causes more deaths each year than all other gynecological cancers combined. The number of prevalent ovarian cancer cases in the seven...

READ ARTICLE

Press-release

Decision Resources Study on Ovarian Cancer Finds That Premium-Priced Monoclonal Antibodies Will Compete for Market Share

Decision Resources Study on Ovarian Cancer Finds That Premium-Priced Monoclonal Antibodies Will Compete for Market Share

Decision Resources, Inc., announces the publication of Ovarian Cancer, a new study that evaluates the commercial potential of novel agents to treat...

READ ARTICLE

Press-release

Decision Resources Study Finds Novel Agents Will Drive Significant Growth in the Severe Sepsis and Septic Shock Treatment Market

Decision Resources Study Finds Novel Agents Will Drive Significant Growth in the Severe Sepsis and Septic Shock Treatment Market

Sepsis and septic shock have been notoriously difficult indications for drug development. However, considering the high incidence of sepsis,...

READ ARTICLE

Press-release

Decision Resources, Inc., Launches Innovative Decision Support Tool for Evaluating and Comparing Drug Development Opportunities in Central Nervous System (CNS) Disorders

Decision Resources, Inc., Launches Innovative Decision Support Tool for Evaluating and Comparing Drug Development Opportunities in Central Nervous System (CNS) Disorders

Decision Resources, Inc., today announced the availability of its new, proprietary decision support tool, COMPETITIVE LANDSCAPE ™ for CNS. Featuring...

READ ARTICLE

Press-release

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

All eyes have been on the first selective COX-2 inhibitors, celecoxib (Pharmacia and Pfizer's Celebrex) and rofecoxib (Merck's Vioxx), for the...

READ ARTICLE

Press-release

Decision Resources Study Evaluates Type 2 Diabetes Therapies in Early- and Late-Stage Development and Forecasts Their Commercial Potential

Decision Resources Study Evaluates Type 2 Diabetes Therapies in Early- and Late-Stage Development and Forecasts Their Commercial Potential

Decision Resources, Inc., announces the publication of Type 2 Diabetes, a new study that evaluates the commercial potential of novel agents to treat...

READ ARTICLE

Press-release

Decision Resources Study Examines Improvements in Diagnostic Technologies and Clinical Trial Design that May Lead to More-Effective Acute Ischemic Stroke Therapies

Decision Resources Study Examines Improvements in Diagnostic Technologies and Clinical Trial Design that May Lead to More-Effective Acute Ischemic Stroke Therapies

Acute Ischemic Stroke is a new study from Decision Resources, Inc., that examines the significant unmet needs in the management of ischemic stroke (IS...

READ ARTICLE